Articles with public access mandates - David RimmLearn more
OverallNIHDoDSusan G. KomenVACancer Research UKHHMIMRCNIHRNHMRCEuropean CommissionHEABreast Cancer Now, UKGovernment of SpainMelanoma Research AllianceNSFCDFGSFISwedish Research CouncilEPSRCANRSCLKWFOICRNSFCCSCIHRA*StarBBSRCWellcomeBMBFGovernment of ItalyDamon Runyon Cancer Research FoundationLung Cancer Research Foundation, USASNSFAHAFRQSINSERMOTKAKnut and Alice Wallenberg FoundationCSOState of CalifoniaSCFUK Research & InnovationAIRC Foundation for Cancer Research in ItalyCPRITRoyal Society UK
Not available anywhere: 6
Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome
M Harigopal, J Heymann, S Ghosh, V Anagnostou, RL Camp, DL Rimm
Breast cancer research and treatment 115, 77-85, 2009
Mandates: US National Institutes of Health
Automated analysis of tissue microarrays
M Dolled-Filhart, M Gustavson, RL Camp, DL Rimm, JL Tonkinson, ...
Tissue Microarrays: Methods and Protocols, 151-162, 2010
Mandates: US National Institutes of Health
Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer
CAW Sullivan, S Ghosh, IT Ocal, RL Camp, DL Rimm, GG Chung
Human pathology 40 (2), 156-165, 2009
Mandates: US National Institutes of Health
Unvalidated antibodies and misleading results
D Rimm, K Schalper, L Pusztai
Breast cancer research and treatment 147, 457-458, 2014
Mandates: US National Institutes of Health
Compactness measures of tumor infiltrating lymphocytes in lung adenocarcinoma are associated with overall patient survival and immune scores
R Ding, P Prasanna, G Corredor, C Lu, P Velu, K Le, P Leo, N Beig, ...
Medical Imaging 2020: Digital Pathology 11320, 1132003, 2020
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Reply to A. Italiano
AR Peck, AK Witkiewicz, C Liu, GA Stringer, AC Klimowicz, EC Pequignot, ...
Journal of Clinical Oncology 29 (35), 4718-4719, 2011
Mandates: US National Institutes of Health
Available somewhere: 276
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
CJ Creighton, X Li, M Landis, JM Dixon, VM Neumeister, A Sjolund, ...
Proceedings of the National Academy of Sciences 106 (33), 13820-13825, 2009
Mandates: US National Institutes of Health, Cancer Research UK
Artificial intelligence in digital pathology—new tools for diagnosis and precision oncology
K Bera, KA Schalper, DL Rimm, V Velcheti, A Madabhushi
Nature reviews Clinical oncology 16 (11), 703-715, 2019
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update
KH Allison, MEH Hammond, M Dowsett, SE McKernin, LA Carey, ...
Journal of Clinical Oncology 38 (12), 1346-1366, 2020
Mandates: US National Institutes of Health
Programmed death ligand-1 expression in non-small cell lung cancer
V Velcheti, KA Schalper, DE Carvajal, VK Anagnostou, KN Syrigos, ...
Laboratory investigation 94 (1), 107-116, 2014
Mandates: US National Institutes of Health
Quantitative assessment of the heterogeneity of PD-L1 expression in non–small-cell lung cancer
J McLaughlin, G Han, KA Schalper, D Carvajal-Hausdorf, V Pelekanou, ...
JAMA oncology 2 (1), 46-54, 2016
Mandates: US National Institutes of Health
Antibody validation
J Bordeaux, AW Welsh, S Agarwal, E Killiam, MT Baquero, JA Hanna, ...
Biotechniques 48 (3), 197-209, 2010
Mandates: US National Institutes of Health
A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer
DL Rimm, G Han, JM Taube, SY Eunhee, JA Bridge, DB Flieder, R Homer, ...
JAMA oncology 3 (8), 1051-1058, 2017
Mandates: US National Institutes of Health
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311-335, 2017
Mandates: US National Institutes of Health, Government of Spain
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235-251, 2017
Mandates: US National Institutes of Health
Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer
S Gettinger, J Choi, K Hastings, A Truini, I Datar, R Sowell, A Wurtz, ...
Cancer discovery 7 (12), 1420-1435, 2017
Mandates: US Department of Defense, US National Institutes of Health
A proposal for validation of antibodies
M Uhlen, A Bandrowski, S Carr, A Edwards, J Ellenberg, E Lundberg, ...
Nature methods 13 (10), 823-827, 2016
Mandates: US National Institutes of Health
Immunotherapy in non–small cell lung cancer: facts and hopes
DB Doroshow, MF Sanmamed, K Hastings, K Politi, DL Rimm, L Chen, ...
Clinical Cancer Research 25 (15), 4592-4602, 2019
Mandates: US National Institutes of Health
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
J Wang, J Sun, LN Liu, DB Flies, X Nie, M Toki, J Zhang, C Song, M Zarr, ...
Nature medicine 25 (4), 656-666, 2019
Mandates: US National Institutes of Health
Comparison of biomarker modalities for predicting response to PD-1/PD-L1 checkpoint blockade: a systematic review and meta-analysis
S Lu, JE Stein, DL Rimm, DW Wang, JM Bell, DB Johnson, JA Sosman, ...
JAMA oncology 5 (8), 1195-1204, 2019
Mandates: US Department of Defense, US National Institutes of Health
Publication and funding information is determined automatically by a computer program